Senate tables hemp amendment at center of funding fight, allowing one-month delay of ban

← Back to the feed

Senate tables hemp amendment at center of funding fight, allowing one-month delay of ban

The Hill · 2 hours ago

The Senate has set aside a proposed amendment concerning hemp-derived THC products during a dispute over government funding, delaying an anticipated federal ban by one month. The move matters because it temporarily preserves the legal position of a market for intoxicating hemp products while lawmakers continue negotiating a broader spending measure.

The amendment was at the centre of a funding fight and would have affected products made from hemp-derived THC, including items sold outside regulated cannabis markets. Rather than resolving the policy question, the Senate’s action postpones it, leaving businesses, consumers and regulators facing continued uncertainty until the new deadline.

  • Senate delays a proposed hemp-derived THC ban by one month.
  • The issue is tied to wider government funding negotiations.
  • The policy dispute remains unresolved.

Both sides, in good faith

The strongest fair case each way — we don't pick a winner.

The case for

Supporters of delaying the ban can argue that Congress should not abruptly remove a widely available product category through a funding dispute, particularly when businesses have made investments under the existing legal framework. A short extension gives lawmakers time to distinguish responsibly produced hemp-derived products from unsafe or misleading ones, and to create clear rules on testing, labelling, age limits and enforcement. They may also stress consumer choice and the importance of avoiding unnecessary disruption to farmers, retailers and workers.

The case against

Supporters of proceeding with a ban can argue that intoxicating hemp-derived THC products have exploited a legal loophole and are often sold outside the safeguards applied to regulated cannabis, creating risks for children, consumers and public health. In their view, another delay prolongs a confusing market in which product potency, quality and access controls can vary sharply between states and sellers. They may contend that a firm federal restriction is needed to close the loophole promptly and prevent commercial interests from outrunning sensible regulation.

Art Culture Elections Geopolitics Government Politics

Read the full article at the source →